SCHEMBL26447356

SCHEMBL26447356

Cc1cccc2ccc3ccc4ccc(Cl)cc4c3c12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
HPGD P15428 3/20 0.47
HSD17B10 Q99714 3/20 0.47
CYP3A4 P08684 1/20 0.47
TSHR P16473 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CYP1A2 P05177 6/20 0.46
CYP2A6 P11509 4/20 0.46
CHEK1 O14757 1/20 0.45
TYMS P04818 3/20 0.43
THRB P10828 1/20 0.39
AR P10275 1/20 0.38
POLB P06746 1/20 0.37
NPFFR1 Q9GZQ6 1/20 0.36
NPFFR2 Q9Y5X5 1/20 0.36
ERBB2 P04626 1/20 0.36
FYN P06241 1/20 0.36
MAOA P21397 1/20 0.36
ACHE P22303 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3275928 0.84 CYP2A6 (0.63) ALDH1A1HPGDHSD17B10CYP3A4TSHR
SCHEMBL597308 0.78 ALDH1A1 (0.62) ALDH1A1HPGDHSD17B10CYP3A4TSHR
SCHEMBL26447355 0.78 CHEK1 (0.45) ALDH1A1HPGDHSD17B10CYP3A4TSHR
SCHEMBL4647758 0.77 CYP1A2 (0.59) ALDH1A1HPGDHSD17B10CYP3A4TSHR
SCHEMBL17792040 0.76 ACHE (0.49) ALDH1A1HPGDCYP2A6CHEK1TYMS
SCHEMBL30887587 0.76 CYP2A6 (0.54) ALDH1A1HPGDHSD17B10CYP3A4TSHR
SCHEMBL1934750 0.76 CYP2A6 (0.54) ALDH1A1HPGDHSD17B10CYP3A4TSHR
SCHEMBL17792042 0.76 CHEK1 (0.46) ALDH1A1HPGDHSD17B10CYP3A4TSHR
SCHEMBL29112073 0.76 CYP1A2 (0.52) ALDH1A1HPGDHSD17B10CYP3A4TSHR
SCHEMBL597448 0.75 CYP1A2 (0.73) ALDH1A1HPGDHSD17B10CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230140483-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2023-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230140483-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OXER1, OCIAD1, OR10J3 ALDH1A1 66/4885HPGD 1565/4885HSD17B10 1150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.